Boserolimab (MK-5890) is a humanized monoclonal antibody targeting CD27 with agonistic activity. It partially blocks the binding of soluble CD70 to CD27-expressing membranes and can be used in lung cancer research.
Purity:
95.00%
CAS Number:
[2444297-08-7]
Target:
TNF|||NF-kappaB
* VAT and and shipping costs not included. Errors and price changes excepted